Abstract
Background: Sugammadex is a reversal agent for non-depolarizing neuromuscular blockers and widely used worldwide on account of its rapid and effective reversal from neuromuscular blockade, despite its advantages, multiple cases of sugammadex-induced anaphylactic shock have been reported. Case: A 42-year-old man developed anaphylactic shock in the postanesthesia care unit. Initially, sugammadex was suspected as the causative agent, but an intradermal skin test revealed negative results. A further skin test was performed with sugammadex-rocuronium complex that yielded positive results. Conclusions: Anesthesiologists and healthcare providers should be aware of the possibility of anaphylaxis from the sugammadex-rocuronium complex, as well as from sugammadex or rocuronium alone.
Author supplied keywords
Cite
CITATION STYLE
Kim, G. H., Choi, W. S., Kim, J. E., Yun, M. J., Koo, M. S., Kwon, M., & Seo, H. (2019). Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex: A case report. Korean Journal of Anesthesiology, 72(5), 495–499. https://doi.org/10.4097/kja.d.18.00232
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.